Hematologic aspects of the porphyrias

Area of Science:

• Biochemistry
• Genetics
• Hematology

Background:

• Porphyrias are a group of inherited or acquired disorders characterized by partial or total deficiency of enzymes in the heme biosynthetic pathway.
• Enzymatic defects at various steps lead to the accumulation and excretion of toxic porphyrins and their precursors.
• Heme pathway gene expression, particularly delta-aminolevulinate synthase, influences tissue-specific porphyria manifestation.

Purpose of the Study:

• To describe the hematologic aspects of erythropoietic porphyrias.
• To provide an overview of the heme biosynthetic pathway and its associated enzyme deficiencies.
• To classify porphyrias based on symptoms and primary site of enzyme defect.

Main Methods:

• Review of existing literature on heme biosynthesis and porphyrias.
• Classification of porphyrias based on enzymatic defects, clinical presentation, and affected tissues.
• Focus on hematologic manifestations of erythropoietic porphyrias.

Main Results:

• Eight enzymes are involved in heme synthesis; defects typically cause accumulation of porphyrins or their precursors.
• Porphyrias can be classified as photosensitive or neurologic, and hepatic or erythropoietic.
• The three major erythropoietic porphyrias discussed are congenital erythropoietic porphyria (CEP), hepatoerythropoietic porphyria (HEP), and erythropoietic protoporphyria (EPP).

Conclusions:

• Enzymatic deficiencies in the heme pathway result in the buildup of toxic porphyrins.
• Understanding the tissue-specific expression of heme pathway genes is crucial for porphyria pathogenesis.
• Hematologic features of CEP, HEP, and EPP are key to diagnosing and managing these erythropoietic porphyrias.